Equipalazone 1 g Oral Paste

Land: Ierland

Taal: Engels

Bron: HPRA (Health Products Regulatory Authority)

Werkstoffen:

Phenylbutazone

Beschikbaar vanaf:

Dechra Ltd

ATC-code:

QM01AA01

INN (Algemene Internationale Benaming):

Phenylbutazone

Dosering:

1.0 gram(s)

farmaceutische vorm:

Oral paste

Prescription-type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutische categorie:

Cattle, Non food-producing horses, Sheep

Therapeutisch gebied:

phenylbutazone

therapeutische indicaties:

N.S.A.I.D.

Autorisatie-status:

Authorised

Autorisatie datum:

2005-10-01

Productkenmerken

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Equipalazone 1 g Oral Paste
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral paste.
Off white paste prefilled into 32 ml syringes
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses and ponies
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Indicated in the treatment of musculoskeletal disorders in horses and
ponies where the anti-inflammatory and analgesic
properties of phenylbutazone can offer relief, for example, in
lameness associated with osteoarthritic conditions, acute
and chronic laminitis, bursitis and carpitis.
4.3 CONTRAINDICATIONS
The therapeutic index of phenylbutazone is low.
Do not exceed the stated dose or duration of treatment.
Use is contra-indicated in animals suffering from cardiac, hepatic or
renal disease, where there is the possibility of
gastro-intestinal ulceration or bleeding, and where there is evidence
of a blood dyscrasia or hypersensitivity to the
product.
Do not administer other NSAIDs concurrently or within 24 hours of each
other.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Discontinue treatment if no response is evident after four to five
days treatment.
The clinical effect of phenylbutazone can be evident for at least
three days following cessation of administration.
This
should be borne in mind when examining horses for soundness.
ACTIVE SUBSTANCE:
Per unit dose % w/w
Phenylbutazone
1.00 g
16.66
EXCIPIENTS:
Sodium Methyl Parahydroxybenzoate 0.006 g
0.10
Sodium Propyl Parahydroxybenzoate 0.0015 g
0.025
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___